Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Mar 20, 2019 at 11:29 AM EDT

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.

Jon C. Ogg | Mar 19, 2019 at 10:25 AM EDT

Bad News for AbbVie and Multiple Myeloma Patients

AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA.

Chris Lange | Mar 19, 2019 at 9:55 AM EDT

What’s Next for Altimmune’s Influenza Vaccine

Altimmune shares surged on Tuesday following results from its midstage study of a intranasal influenza vaccine candidate.

Chris Lange | Mar 18, 2019 at 10:40 AM EDT

Dermira’s Eczema Treatment Lebrikizumab Breaks Through

Dermira shares more than doubled on Monday after the firm announced midstage results from its Eczema study.

Chris Lange | Mar 18, 2019 at 9:55 AM EDT

What Its Antiplatelet Reversal Agent Means for PhaseBio Going Forward

PhaseBio shares more than doubled on Monday after the firm released results from an early-stage clinical trial of its antiplatelet…

Lee Jackson | Mar 16, 2019 at 7:10 AM EDT

5 Sizzling Biotech Stocks Under $10 With Gigantic Upside Potential

We screened our 24/7 Wall St. research database and found five biotech stocks trading under the $10 level that could…

Chris Lange | Mar 15, 2019 at 10:05 AM EDT

Can Karyopharm’s Myeloma Treatment Selinexor Pass Muster?

Karyopharm shares jumped on Friday after the firm announced an FDA update from the FDA on its treatment for myeloma.

Chris Lange | Mar 14, 2019 at 1:45 PM EDT

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

Johnson & Johnson shares dipped on Thursday on news that a California jury awarded $29 million to a woman that…

Chris Lange | Mar 12, 2019 at 10:45 AM EDT

Vadadustat Makes the Case for Blockbuster Status After Japanese Chronic Kidney Disease Studies

Patients suffering anemia due to chronic kidney disease are sure to be content with new positive top-line results from two…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 11, 2019 at 4:14 PM EDT

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA)…

Chris Lange | Mar 11, 2019 at 11:15 AM EDT

Why Investors Are Hyped for Tonix Pharma’s PTSD Late-Stage Trial

Tonix Pharma shares made a solid gain on Monday after the firm announced that it is beginning to enroll patients…

Chris Lange | Mar 11, 2019 at 9:50 AM EDT

What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant

Axovant Sciences has produced results from two separate studies related to neurodegenerative diseases, and its shares had a sharp gain…

Douglas A. McIntyre | Mar 10, 2019 at 7:49 AM EDT

Do E-Cigarettes Cause A Surge In Heart Attack Risk?

There has been little exact proof about how much damage e-cigarettes can do to health. Also know as “e-cigs,” “vapes,”…

1 … 103 104 105 106 107 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Bad News for AbbVie and Multiple Myeloma Patients

What’s Next for Altimmune’s Influenza Vaccine

Dermira’s Eczema Treatment Lebrikizumab Breaks Through

What Its Antiplatelet Reversal Agent Means for PhaseBio Going Forward

5 Sizzling Biotech Stocks Under $10 With Gigantic Upside Potential

Can Karyopharm’s Myeloma Treatment Selinexor Pass Muster?

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

Vadadustat Makes the Case for Blockbuster Status After Japanese Chronic Kidney Disease Studies

Major Biotechs See a Rising Tide in Short Interest

Big Pharma Short Interest Backs Off, With One Huge Exception

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Why Investors Are Hyped for Tonix Pharma’s PTSD Late-Stage Trial

What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant

Do E-Cigarettes Cause A Surge In Heart Attack Risk?

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

Retirees Get a $12,000 Deduction in 2026. Pair It With the 14% Income Fund the IRS Barely Touches

At 63, He Entered Maine’s Free Shipyard Training While Collecting Unemployment and Social Security. Then the Paycheck Changed the Math.

The $1 Million 401(k) Strategy That Doubles Your Annual Payout Before Age 59.5

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Bad News for AbbVie and Multiple Myeloma Patients

What’s Next for Altimmune’s Influenza Vaccine

Dermira’s Eczema Treatment Lebrikizumab Breaks Through

What Its Antiplatelet Reversal Agent Means for PhaseBio Going Forward

5 Sizzling Biotech Stocks Under $10 With Gigantic Upside Potential

Can Karyopharm’s Myeloma Treatment Selinexor Pass Muster?

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

Vadadustat Makes the Case for Blockbuster Status After Japanese Chronic Kidney Disease Studies

Major Biotechs See a Rising Tide in Short Interest

Big Pharma Short Interest Backs Off, With One Huge Exception

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Why Investors Are Hyped for Tonix Pharma’s PTSD Late-Stage Trial

What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant

Do E-Cigarettes Cause A Surge In Heart Attack Risk?

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

Retirees Get a $12,000 Deduction in 2026. Pair It With the 14% Income Fund the IRS Barely Touches

Featured Reads

At 63, He Entered Maine’s Free Shipyard Training While Collecting Unemployment and Social Security. Then the Paycheck Changed the Math.

The $1 Million 401(k) Strategy That Doubles Your Annual Payout Before Age 59.5